Z-D-Dap(Aloc)-OH*DCHA is a protected, non-proteinogenic/modified amino acid derivative based on 2,3-diaminopropanoic acid (Dap) featuring an Aloc (allyloxycarbonyl) protecting group on one amino functionality and a Z (benzyloxycarbonyl/Cbz-type) carbamate protection pattern on the remaining amino-derived functionality, with a free carboxylic acid present as indicated by the "-OH." The "D" designation specifies the stereochemical form at the amino acid center, while the "*DCHA" denotes association with dicyclohexylamine (DCHA), and the molecule therefore bears both an amino acid carboxyl group and protected amine(s) that modulate chemoselectivity during peptide-coupling chemistry. Z-D-Dap(Aloc)-OH*DCHA is employed as a building block for stepwise peptide synthesis and related amino acid derivatization workflows where orthogonal deprotection of the Aloc group and controlled handling of the diamino side chain are required for preparing defined peptide or peptidomimetic structures.
CAT No: CP25265
CAS No:1263046-49-6
Synonyms/Alias:N-alpha-Z-N-beta-Alloc-D-2,3-diaminopropionic acid*DCHA;Z-D-Dap(Alloc)*DCHA;Z-D-Dpr(Aloc)*DCHA;Z-D-Dapa(Aloc)*DCHA
Chemical Name:N-alpha-Benzyloxycarbonyl-N-beta-allyloxycarbonyl-D-2,3-diaminopropionic acid dicyclohexylamine
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.